Menorrhagia

• FDA approval · 2022-06-23
  FDA Approved: TRANEXAMIC ACID — Supplemental Application (Mylan Institutional LLC)

  FDA approved a supplemental application for tranexamic acid submitted by Mylan Institutional LLC. This action authorizes the continued comme…

• FDA approval · 2020-06-25
  FDA Approved: TRANEXAMIC ACID — Supplemental Application (XGen Pharmaceuticals DJB, Inc.)

  The FDA approved a supplemental application for tranexamic acid submitted by XGen Pharmaceuticals DJB, Inc. under an ANDA, indicating regula…

• FDA approval · 2018-05-14
  FDA Approved: TRANEXAMIC ACID — Supplemental Application (Mylan Institutional LLC)

  FDA approved a supplemental application for tranexamic acid from Mylan Institutional LLC, granting approval for the generic product.

• FDA approval · 2013-06-14
  FDA Approved: TRANEXAMIC ACID — Original Application (XGen Pharmaceuticals DJB, Inc.)

  FDA approved the original application for tranexamic acid from XGen Pharmaceuticals DJB, Inc., authorizing a generic version of the antifibr…

• FDA approval · 2012-12-27
  FDA Approved: TRANEXAMIC ACID — Original Application (Actavis Pharma, Inc.)

  FDA approved a generic tranexamic acid product from Actavis Pharma, Inc. under an Original Application; tranexamic acid is used to prevent o…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2012-03-02
  FDA Approved: TRANEXAMIC ACID — Original Application (Fresenius Kabi USA, LLC)

  FDA approves the original application for tranexamic acid as a generic product from Fresenius Kabi USA, LLC. This marks the entry of a gener…